ADAP
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
13.97M
62 days until earnings call
NVO
Price
$56.14
Change
-$0.60 (-1.06%)
Updated
Sep 4, 04:59 PM (EDT)
Capitalization
252.56B
62 days until earnings call
Interact to see
Advertisement

ADAP vs NVO

Header iconADAP vs NVO Comparison
Open Charts ADAP vs NVOBanner chart's image
Adaptimmune Therapeutics
Price$0.05
Change-$0.00 (-0.00%)
Volume$136.12K
Capitalization13.97M
Novo-Nordisk A/S
Price$56.14
Change-$0.60 (-1.06%)
Volume$34.18K
Capitalization252.56B
ADAP vs NVO Comparison Chart in %
Loading...
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ADAP vs. NVO commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ADAP is a Hold and NVO is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (ADAP: $0.05 vs. NVO: $56.74)
Brand notoriety: ADAP and NVO are both not notable
ADAP represents the Biotechnology, while NVO is part of the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ADAP: 80% vs. NVO: 51%
Market capitalization -- ADAP: $13.97M vs. NVO: $252.56B
ADAP [@Biotechnology] is valued at $13.97M. NVO’s [@Pharmaceuticals: Major] market capitalization is $252.56B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $661.43B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B. The average market capitalization across the [@Pharmaceuticals: Major] industry is $90.22B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ADAP’s FA Score shows that 0 FA rating(s) are green whileNVO’s FA Score has 2 green FA rating(s).

  • ADAP’s FA Score: 0 green, 5 red.
  • NVO’s FA Score: 2 green, 3 red.
According to our system of comparison, NVO is a better buy in the long-term than ADAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ADAP’s TA Score shows that 5 TA indicator(s) are bullish while NVO’s TA Score has 4 bullish TA indicator(s).

  • ADAP’s TA Score: 5 bullish, 2 bearish.
  • NVO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ADAP is a better buy in the short-term than NVO.

Price Growth

ADAP (@Biotechnology) experienced а -11.89% price change this week, while NVO (@Pharmaceuticals: Major) price change was +0.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.27%. For the same industry, the average monthly price growth was +7.08%, and the average quarterly price growth was +29.28%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.37%. For the same industry, the average monthly price growth was +1.83%, and the average quarterly price growth was +9.29%.

Reported Earning Dates

ADAP is expected to report earnings on Nov 05, 2025.

NVO is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

@Pharmaceuticals: Major (+0.37% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NVO($253B) has a higher market cap than ADAP($14M). NVO YTD gains are higher at: -32.220 vs. ADAP (-90.236).
ADAPNVOADAP / NVO
Capitalization14M253B0%
EBITDA-149.75MN/A-
Gain YTD-90.236-32.220280%
P/E RatioN/A14.49-
Revenue65.1MN/A-
Total Cash26.1MN/A-
Total Debt48.7MN/A-
FUNDAMENTALS RATINGS
ADAP vs NVO: Fundamental Ratings
ADAP
NVO
OUTLOOK RATING
1..100
8518
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
16
Undervalued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
10015
PRICE GROWTH RATING
1..100
9864
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NVO's Valuation (16) in the Pharmaceuticals Major industry is in the same range as ADAP (47) in the Biotechnology industry. This means that NVO’s stock grew similarly to ADAP’s over the last 12 months.

NVO's Profit vs Risk Rating (77) in the Pharmaceuticals Major industry is in the same range as ADAP (100) in the Biotechnology industry. This means that NVO’s stock grew similarly to ADAP’s over the last 12 months.

NVO's SMR Rating (15) in the Pharmaceuticals Major industry is significantly better than the same rating for ADAP (100) in the Biotechnology industry. This means that NVO’s stock grew significantly faster than ADAP’s over the last 12 months.

NVO's Price Growth Rating (64) in the Pharmaceuticals Major industry is somewhat better than the same rating for ADAP (98) in the Biotechnology industry. This means that NVO’s stock grew somewhat faster than ADAP’s over the last 12 months.

NVO's P/E Growth Rating (98) in the Pharmaceuticals Major industry is in the same range as ADAP (100) in the Biotechnology industry. This means that NVO’s stock grew similarly to ADAP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ADAPNVO
RSI
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
68%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
64%
Momentum
ODDS (%)
N/A
Bullish Trend 2 days ago
71%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
66%
Advances
ODDS (%)
Bullish Trend 8 days ago
78%
Bullish Trend 14 days ago
67%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 10 days ago
59%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
43%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ADAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NXTC4.980.05
+1.01%
NextCure Inc
MED13.960.04
+0.29%
Medifast
TGNA21.17N/A
N/A
TEGNA
VLTO105.07-0.21
-0.20%
Veralto Corp
RYI22.42-0.19
-0.84%
RYERSON HOLDING Corp

ADAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ADAP has been loosely correlated with NEVPF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ADAP jumps, then NEVPF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ADAP
1D Price
Change %
ADAP100%
-9.00%
NEVPF - ADAP
56%
Loosely correlated
N/A
AKBA - ADAP
41%
Loosely correlated
+0.32%
CSLLY - ADAP
32%
Poorly correlated
+0.24%
ATXS - ADAP
30%
Poorly correlated
+6.07%
CRSP - ADAP
30%
Poorly correlated
+0.61%
More

NVO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NVO has been loosely correlated with ADAP. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if NVO jumps, then ADAP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NVO
1D Price
Change %
NVO100%
+0.64%
ADAP - NVO
38%
Loosely correlated
-9.00%
GMAB - NVO
35%
Loosely correlated
+4.60%
TECH - NVO
35%
Loosely correlated
-0.15%
BCAB - NVO
35%
Loosely correlated
+9.06%
MRK - NVO
34%
Loosely correlated
-1.52%
More